(14-09-2017, 03:46 PM)Aria Wrote: (14-09-2017, 09:11 AM)Shawna-lee Wrote: There is hope for those who despair with lack of growth (I truly believe that), everyones different, it's just a matter of finding the right combination of things.
Of which I am one
How do you think blood type affects NBE and HRT?
Great Question! ! There ya go Lotus, Sick 'Em! !
that is a great question, I don't think we've ever factored blood types into NBE/Hrt, here's what I found.
type A & AB have higher levels of cortisol, and generally, cortisol (if not used properly) will hurt breast growth, in other words, Type O blood produces less cortisol (less of an obstacle for breast growth). Putting high stress (which sends cortisol super sonic in the wrong direction) to work for us means exercise...and I mean HIIT (high intensity interval training). The repair peptides unleashed by HIIT are (sic) unbleivable, and supplementing NBE/Hrt post workout (with growth promoting proteins)....e.g. whey protein or casein, plus NBE herbs or HRT takes breast growth to the next level. i prefer casein + glycine.+ collagen w/vitamin D, L-tyrosine, glutamine plus E2/MSM and Spiro.
here's one example (below) on using glycine (prolin is also pro breast growth too). Essentially, whats missing in NBE/Hrt is growth hormone/IGF-....or rather stimulating the two IN combination with E2. In combination therapy (for NBE/Hrt) everything work simultaneously....mutiple studies have already proved that combo therapy produces better results over standard single delivery (which I believed 2-3 years ago single use delivery was the gold standard, not amymore).
Cyclic glycine-proline regulates IGF-1 homeostasis by altering the binding of IGFBP-3 to IGF-1
https://www.researchgate.net/publication...3_to_IGF-1
In this cohort study below a sampling of blood types revealed how different blood hormone status effects cancer types.
Blood Type, Hormone Receptor Status, HER2/neu Status, and Survival in Breast Cancer: A Retrospective Study Exploring Relationships in a Phenotypically Well-Defined Cohort
www.ncbi.nlm.nih.gov/pmc/articles/PMC3251447/
Persons with blood type B (83.7%) and blood type A (75.7%) had smaller tumors (<2cm on average) than persons who were blood type AB (68.2%) or blood type O (61.7%).
The presence of progesterone receptors demonstrates an active ER mechanism for the induction of PR expression. Notably, blood group B individuals also exhibited the highest rates of ER/PR positivity which is considered a favorable prognostic factor in breast carcinoma.
so what's the take away here?....my opinion?...the antigens in blood types (or lack thereof) needs to be better explored and defined for NBE/Hrt. Though the conclusion of the study states the follwing.
Conclusion No significant differences were observed in overall and disease-free survival based on blood group. No correlation was noted between HER2/neu, ER or PR status, and blood group type. Among this cohort, HER2/neu positivity was less than 20% and correlated with a 5-year disease-free survival rate ≥75% and overall survival of >80% across all blood groups.